Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

Comparing the effectiveness of tofacitinib extended release (XR) chronotherapy, morning versus evening dosing, in rheumatoid arthritis (RA) … Recruiting

2024-517865-17-01 Rheumatoid arthritis or psoriatic arthritis according t 6 2024-09-30
A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch an… Recruiting

2024-517764-38-00 Pouchitis 9 2024-09-27
NOVEL TREATMENT OF DIABETIC FOOT ULCER BY AUTOLOGOUS STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE Recruiting

2024-516342-19-00 Diabetic Foot ulcERs 4 2024-09-13
Prospective, multicentre, open-label clinical trial on the effect of GUSelkumab on the resolution of ultrasound-proven ENThEsitis in patient… Recruiting

2024-512459-19-00 Psoriatic arthritis 6 2024-09-13
A study of efgartigimod PH20 SC in children between 2 and less than 18 years of age with generalized myasthenia gravis Recruiting

2023-506159-12-00 Generalized Myasthenia Gravis 10 2024-09-06
Long-term clinical trial of PQ Grass in paediatric subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by grass poll… Recruiting

2023-508520-36-00 Seasonal allergic rhinitis/rhinoconjunctivitis induced 5 2024-09-06
Comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS Recruiting

2023-505051-43-00 juvenile idiopathic arthritis 5 2024-09-04
Treatment with leflunomide in patients with polymyalgia rheumatica Recruiting

2024-514210-12-00 polymyalgia rheumatica 5 2024-09-01
Optimizing treatment strategy in axial spondyloarthritis by molecular imaging with Technetium-labeled certolizumab pegol. Recruiting

2023-505694-32-00 Axial Spondyloarthritis 5 2024-08-29
Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial) Recruiting

2023-507692-21-00 Bullous pemphigoid 3 2024-08-22
A study to learn how bimekizumab works in children and teenagers with moderate to severe plaque psoriasis Recruiting

2023-503859-10-00 Moderate to Severe Plaque Psoriasis 5 2024-08-12
MB-CART19.1 in refractory SLE Recruiting

2023-507654-33-00 Refractory systemic lupus erythematosus (SLE) 9 2024-08-12
STRATIFY; Near-infrared fluorescence molecular imaging of adalimumab-800CW to elucidate the drug distribution throughout inflamed tissue in … Recruiting

2024-513390-50-00 Crohn's disease 3 2024-08-06
A study to test the effects and safety of riliprubart in people with chronic inflammatory demyelinating polyneuropathy (CIDP) for which the … Recruiting

2023-506503-26-00 Polyneuropathy, Inflammatory Demyelinating, Chronic 5 2024-07-31
HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial… Recruiting

2022-502155-65-00 Extra pulmonary sarcoidosis 5 2024-07-30
A study to investigate efficacy, safety, and tolerability of mavorixafor in participants with congenital and acquired primary autoimmune and… Recruiting

2023-508482-32-00 Neutropenias 5 2024-07-22
Randomized Phase 2 study testing two conditioning regimen with a single prophylaxis of graft-versus-host disease by cyclophosphamide and met… Recruiting

2023-509042-35-01 Adults patients will be included in the hematology depa 4 2024-07-18
A first-in-human study of the safety of an immunosuppressive antibody (IMP761) in healthy volunteers. Recruiting

2024-510761-42-00 autoimmunity 1 2024-07-17
A Phase 3 Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) Recruiting

2022-502629-16-00 Hemolytic Disease of the Fetus and Newborn (HDFN) 5 2024-07-10
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Generalized Myasthenia Gravis Recruiting

2023-509892-17-00 Generalized myasthenia gravis 10 2024-07-09
“Randomized controlled multicenter study comparing efficacy and safety of adalimumab to that of mycophenolate mofetil in steroid dependent n… Recruiting

2023-505112-38-00 recently active non-infectious intermediate, posterior, 11 2024-07-01
MethMax trial Recruiting

2023-507714-27-00 Rheumatoid Arthritis 6 2024-06-20
A Single-Arm, Open-Label, Phase 1 Study to Determine the Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patient… Recruiting

2023-508236-60-00 Severe, Refractory Systemic Lupus Erythematosus 3 2024-06-13
Randomized controlled trial in patients on long-term colchicine with colchicine-resistant familial Mediterranean fever (FMF) to evaluate the… Recruiting

2023-506721-11-00 Familial Mediterranean Fever (FMF) 5 2024-06-04